City of Hope shows outreach to bone marrow transplant survivors and their primary care doctors can markedly cut skin cancer risk
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Oct-2026 12:17 ET (24-Oct-2026 16:17 GMT/UTC)
New collaborative research from multiple departments at VCU—including VCU Massey Comprehensive Cancer Center—points to a specific multifunctional protein, MDA-9, as a significant driver of head and neck tumors and a mediator of drug resistance. The findings of this study suggest that a new small molecule inhibitor, IVMT-Rx-4, could open the door for enhanced targeted treatment options for head and neck squamous cell carcinoma (HNSCC).